1. Home
  2. RCKT vs QRTEB Comparison

RCKT vs QRTEB Comparison

Compare RCKT & QRTEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • QRTEB
  • Stock Information
  • Founded
  • RCKT 1999
  • QRTEB 1991
  • Country
  • RCKT United States
  • QRTEB United States
  • Employees
  • RCKT N/A
  • QRTEB N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • QRTEB Catalog/Specialty Distribution
  • Sector
  • RCKT Health Care
  • QRTEB Consumer Discretionary
  • Exchange
  • RCKT Nasdaq
  • QRTEB Nasdaq
  • Market Cap
  • RCKT 1.3B
  • QRTEB 1.2B
  • IPO Year
  • RCKT N/A
  • QRTEB N/A
  • Fundamental
  • Price
  • RCKT $11.74
  • QRTEB $2.69
  • Analyst Decision
  • RCKT Strong Buy
  • QRTEB
  • Analyst Count
  • RCKT 11
  • QRTEB 0
  • Target Price
  • RCKT $50.27
  • QRTEB N/A
  • AVG Volume (30 Days)
  • RCKT 1.3M
  • QRTEB 8.5K
  • Earning Date
  • RCKT 11-07-2024
  • QRTEB 11-07-2024
  • Dividend Yield
  • RCKT N/A
  • QRTEB N/A
  • EPS Growth
  • RCKT N/A
  • QRTEB N/A
  • EPS
  • RCKT N/A
  • QRTEB N/A
  • Revenue
  • RCKT N/A
  • QRTEB $10,236,000,000.00
  • Revenue This Year
  • RCKT N/A
  • QRTEB N/A
  • Revenue Next Year
  • RCKT $234,928.88
  • QRTEB N/A
  • P/E Ratio
  • RCKT N/A
  • QRTEB N/A
  • Revenue Growth
  • RCKT N/A
  • QRTEB N/A
  • 52 Week Low
  • RCKT $11.58
  • QRTEB $2.66
  • 52 Week High
  • RCKT $32.53
  • QRTEB $7.69
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 27.69
  • QRTEB 35.95
  • Support Level
  • RCKT $11.58
  • QRTEB $2.66
  • Resistance Level
  • RCKT $15.00
  • QRTEB $3.21
  • Average True Range (ATR)
  • RCKT 0.82
  • QRTEB 0.41
  • MACD
  • RCKT -0.09
  • QRTEB -0.05
  • Stochastic Oscillator
  • RCKT 4.65
  • QRTEB 1.85

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About QRTEB Qurate Retail Inc. Series B

Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, using their televised shopping programs and via the Internet through their websites and mobile applications; QVC International segment markets and sells a wide variety of consumer products in several foreign countries, using its televised shopping programs and via the Internet through its international websites and mobile applications; and Zulily markets and sells a wide variety of consumer products in the United States and several foreign countries. Geographically, the company operates in U.S, which generates key revenue, Japan, Germany and other regions.

Share on Social Networks: